Author(s):
Swarupananda Mukherjee, Subhasis Maity, Bijaya Ghosh, Arijit Mondal
Email(s):
arijit.mondal@nshm.com
DOI:
10.5958/0974-360X.2020.00589.2 
Address:
Swarupananda Mukherjee, Subhasis Maity, Bijaya Ghosh, Arijit Mondal*
Department of Pharmacy, NSHM Knowledge Campus, Kolkata - Group of Institutions, Kolkata 700 053, India.
*Corresponding Author
Published In:
Volume - 13,
Issue - 7,
Year - 2020
ABSTRACT:
Solid lipid nanoparticles (SLNs) of glyburide with different lipids like palmitic acid, stearic acid, oleic acid, glyceryl monostearate were prepared by microemulsion dispersion technique. A short-term stability study of lyophilized preformulated SLNs containing the glyburide loaded different solid lipids were performed. Different stability parameters like particle size, polydispersity index (PDI), zeta potential were evaluated to optimize the best formula. Formulation with glyceryl monostearate showed the most stable form with their less particle size and acceptable polydispersity index and zeta potential. Therefore, SLNs with glyceryl monostearate considered for the further formulation design.
Cite this article:
Swarupananda Mukherjee, Subhasis Maity, Bijaya Ghosh, Arijit Mondal. Accelerated Stability study of Preformulated glyburide loaded Lyophilized lipid Nanoparticles. Research J. Pharm. and Tech. 2020; 13(7): 3323-3325. doi: 10.5958/0974-360X.2020.00589.2
Cite(Electronic):
Swarupananda Mukherjee, Subhasis Maity, Bijaya Ghosh, Arijit Mondal. Accelerated Stability study of Preformulated glyburide loaded Lyophilized lipid Nanoparticles. Research J. Pharm. and Tech. 2020; 13(7): 3323-3325. doi: 10.5958/0974-360X.2020.00589.2 Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-7-49
REFERENCES:
1. Molina M, Anchordoquy TJ. Degradation of lyophilized lipid/DNA complexes during storage: the role of lipid and reactive oxygen species. Biochim Biophys Acta. 2008; 1778 (10): 2119–2126.
2. Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm. 2000; 50(1): 161-77.
3. Nepal PR, Han HK, Choi HK. Enhancement of solubility and dissolution of Coenzyme Q10 using solid dispersion formulation. Int J Pharm. 2010; 383(1-2):147-53.
4. Mukherjee S, Ray S, Thakur RS. Solid Lipid Nanoparticles: A Modern Formulation Approach in Drug Delivery System. Indian J Pharm Sci. 2009; 71(4): 349–358.
5. Zhang J, Fan Y, Smith E. Experimental design for the optimization of lipid nanoparticles. J Pharm Sci. 2009; 98(5): 1813–1819.
6. Han F, Li S, Yin R, Liu H, Xu L. Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: Nanostructured lipid carriers. Colloid Surface A. 2008; 315(1-3): 210–216.
7. Schwarz C. Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization., J Microencapsul. 1999; 16(2): 205–213.
8. Pozo-Rodríguez A, Solinís MA Gascón AR Pedraz JL Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy. European Journal of Pharmaceutics and Biopharmaceutics. 2009;71 (2): 181–189.